<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0207321</article-id>
<article-id pub-id-type="publisher-id">PONE-D-18-24463</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Stem cells</subject><subj-group><subject>Cell potency</subject><subj-group><subject>Pluripotency</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Signal transduction</subject><subj-group><subject>Cell signaling</subject><subj-group><subject>Signaling cascades</subject><subj-group><subject>ERK signaling cascade</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Growth factors</subject><subj-group><subject>Fibroblast growth factor</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Growth factors</subject><subj-group><subject>Fibroblast growth factor</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Growth factors</subject><subj-group><subject>Fibroblast growth factor</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Embryology</subject><subj-group><subject>Embryos</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Stem cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Stem cells</subject><subj-group><subject>Embryonic stem cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Cell differentiation</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>DNA-binding proteins</subject><subj-group><subject>Transcription factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>Gene regulation</subject><subj-group><subject>Transcription factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Regulatory proteins</subject><subj-group><subject>Transcription factors</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title><italic>Klf5</italic> suppresses ERK signaling in mouse pluripotent stem cells</article-title>
<alt-title alt-title-type="running-head">Suppression of pERK by <italic>Klf5</italic> in mouse ESCs</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Azami</surname>
<given-names>Takuya</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Matsumoto</surname>
<given-names>Ken</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jeon</surname>
<given-names>Hyojung</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Waku</surname>
<given-names>Tsuyoshi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Muratani</surname>
<given-names>Masafumi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Niwa</surname>
<given-names>Hitoshi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Takahashi</surname>
<given-names>Satoru</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0645-6183</contrib-id>
<name name-style="western">
<surname>Ema</surname>
<given-names>Masatsugu</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff010"><sup>10</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science, Seta, Tsukinowa-cho, Otsu, Shiga, Japan</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Genome Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Pluripotent Stem Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Chuo-ku, Kumamoto, Japan</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>International Institute for Integrative Sleep Medicine (IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Life Science Center (TARA), University of Tsukuba, Tsukuba, Ibaraki, Japan</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Transborder Medical Research Center (TMRC), University of Tsukuba, Tsukuba, Ibaraki, Japan</addr-line></aff>
<aff id="aff009"><label>9</label> <addr-line>Laboratory Animal Resource Center (LARC), University of Tsukuba, Tsukuba, Ibaraki, Japan</addr-line></aff>
<aff id="aff010"><label>10</label> <addr-line>PRESTO, Japan Science and Technology Agency, Saitama, Japan</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Akagi</surname>
<given-names>Tadayuki</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>JAPAN</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">mema@belle.shiga-med.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>11</issue>
<elocation-id>e0207321</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Azami et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0207321"/>
<abstract>
<p>Mouse embryonic stem cells (ESCs) are pluripotent stem cells, which have the ability to differentiate into all three germ layers: mesoderm, endoderm, and ectoderm. Proper levels of phosphorylated extracellular signal-regulated kinase (pERK) are critical for maintaining pluripotency, as elevated pERK evoked by fibroblast growth factor (FGF) receptor activation results in differentiation of ESCs, while, conversely, reduction of pERK by a MEK inhibitor maintains a pluripotent ground state. However, mechanisms underlying proper control of pERK levels in mouse ESCs are not fully understood. Here, we find that Klf5, a Krüppel-like transcription factor family member, is a component of pERK regulation in mouse ESCs. We show that ERK signaling is overactivated in <italic>Klf5</italic>-KO ESCs and the overactivated ERK in <italic>Klf5</italic>-KO ESCs is suppressed by the introduction of <italic>Klf5</italic>, but not <italic>Klf2</italic> or <italic>Klf4</italic>, indicating a unique role for <italic>Klf5</italic> in ERK suppression. Moreover, <italic>Klf5</italic> regulates <italic>Spred1</italic>, a negative regulator of the FGF-ERK pathway. <italic>Klf5</italic> also facilitates reprogramming of EpiSCs into a naïve state in combination with a glycogen synthase kinase 3 inhibitor and LIF, and in place of a MEK inhibitor. Taken together, these results show for the first time that Klf5 has a unique role suppressing ERK activity in mouse ESCs.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100009023</institution-id>
<institution>Precursory Research for Embryonic Science and Technology</institution>
</institution-wrap>
</funding-source>
<award-id>2011</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0645-6183</contrib-id>
<name name-style="western">
<surname>Ema</surname>
<given-names>Masatsugu</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by a grant number 2011 from Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (M.E.). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<page-count count="14"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Pluripotent stem cells (PSCs) can be established as embryonic stem cells (ESCs) in culture from the epiblast of a blastocyst [<xref ref-type="bibr" rid="pone.0207321.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0207321.ref002">2</xref>]. PSCs can also be generated as induced pluripotent stem cells (iPSCs) through the induction of pluripotency from somatic cells by ectopic expression of defined factors such as Oct3/4, Sox2, Klf4, and c-Myc [<xref ref-type="bibr" rid="pone.0207321.ref003">3</xref>]. Pluripotency of mouse ESCs is regulated by extracellular stimuli such as leukemia inhibitory factor (LIF) [<xref ref-type="bibr" rid="pone.0207321.ref004">4</xref>], as well as nuclear factors such as Oct3/4, Sox2, and Nanog [<xref ref-type="bibr" rid="pone.0207321.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0207321.ref009">9</xref>]. Pluripotency is also achieved by the combinatorial inhibition of extracellular signal-regulated kinase (ERK) signaling and glycogen synthase kinase 3β (GSK3β), called the ground state [<xref ref-type="bibr" rid="pone.0207321.ref010">10</xref>]. Conversely, extracellular stimuli elicited by fibroblast growth factor (FGF) activates the ERK pathway in mouse ESCs, thereby destabilizing the pluripotent state and promoting cellular differentiation [<xref ref-type="bibr" rid="pone.0207321.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0207321.ref012">12</xref>].</p>
<p>Mouse epiblast stem cells (EpiSCs) are PSCs derived from post-implantation epiblast at E5.5, the egg cylinder stage [<xref ref-type="bibr" rid="pone.0207321.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0207321.ref014">14</xref>]. Although EpiSCs retain the ability to differentiate into all three germ layers, EpiSCs hardly contribute to fetal tissues when injected into a blastocyst. Mouse EpiSCs and human ESCs share many properties such as gene expression patterns, epigenetic modifications, proliferative activities, and cytokine responsiveness [<xref ref-type="bibr" rid="pone.0207321.ref015">15</xref>]. Both EpiSCs and human ESCs depend on basic FGF and activin signaling for self-renewal, indicating that responsiveness of the FGF-ERK pathway is substantially different between mouse ESCs and human ESCs. PSCs capable of contributing to a chimera are defined to be in a naïve state, while PSCs that depend on FGF signaling and are incapable of contributing to chimeras are in a primed state [<xref ref-type="bibr" rid="pone.0207321.ref015">15</xref>]. A substantial number of studies have demonstrated that naïve PSCs differentiate into primed PSCs [<xref ref-type="bibr" rid="pone.0207321.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0207321.ref017">17</xref>], while primed PSCs can be converted into the naïve state by defined factors such as Nanog and Klf2 [<xref ref-type="bibr" rid="pone.0207321.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0207321.ref020">20</xref>].</p>
<p>Krüppel-like transcription factor family members (Klfs) such as Klf2, Klf4, and Klf5 have important functions in both maintenance of mouse ESC pluripotency and the cellular reprogramming process [<xref ref-type="bibr" rid="pone.0207321.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0207321.ref021">21</xref>–<xref ref-type="bibr" rid="pone.0207321.ref026">26</xref>]. Previous studies clearly demonstrated an association between expression of Klfs and naïve pluripotency, and the self-renewal capacity of mouse ESCs was severely reduced when <italic>Klf2</italic>, <italic>Klf4</italic>, and <italic>Klf5</italic> were knocked down [<xref ref-type="bibr" rid="pone.0207321.ref021">21</xref>] or knocked out (KO) [<xref ref-type="bibr" rid="pone.0207321.ref026">26</xref>]. While <italic>Klf2</italic>, <italic>Klf4</italic>, and <italic>Klf5</italic> have redundant functions in the maintenance of pluripotency, our previous report indicated that <italic>Klf5</italic>-KO mouse ESCs exhibit a spontaneous differentiation phenotype [<xref ref-type="bibr" rid="pone.0207321.ref022">22</xref>]. Our recent study demonstrated overactivation of the ERK pathway in <italic>Klf5</italic>-KO preimplantation embryos and promotion of primitive endoderm specification of inner cell mass cells at the expense of epiblast in <italic>Klf5</italic>-KO embryos [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>]. However, it is unknown whether <italic>Klf5</italic> regulates FGF-ERK pathway in mouse ESCs.</p>
<p>Here, we show overactivation of ERK in <italic>Klf5</italic>-KO ESCs. Importantly, such overactivation is suppressed by the introduction of <italic>Klf5</italic>, but not <italic>Klf2</italic> or <italic>Klf4</italic>, indicating a unique role of <italic>Klf5</italic> in ERK suppression. <italic>Klf5</italic> regulates <italic>Spred1</italic>, a negative regulator of the FGF-ERK pathway. <italic>Klf5</italic> facilitates reprogramming of EpiSCs into a naïve state in combination with a GSK3 inhibitor and LIF, and in place of MEK inhibition. Taken together, our results demonstrate for the first time that Klf5 has a unique role in suppressing ERK activity in mouse ESCs.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Loss of <italic>Klf5</italic> results in an increased level of pERK in mouse ESCs</title>
<p>Proper levels of pERK are critical for maintaining pluripotency, yet how pERK levels are properly controlled in mouse ESCs is not fully understood. As our recent study showed that the ERK pathway is repressed by the transcription factor Klf5 in preimplantation mouse embryos [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>], we examined whether <italic>Klf5</italic> regulates ERK signaling in mouse ESCs. To evaluate pERK levels in only Oct3/4-positive PSCs, new <italic>Klf5</italic>-KO ESC lines were generated from Oct3/4-CFP::Rex1-GFP (OCRG9) ESCs in which a puromycin resistance gene was introduced into the <italic>Oct3/4</italic> locus (<xref ref-type="fig" rid="pone.0207321.g001">Fig 1A and 1B</xref>), thereby enabling rapid selection of Oct3/4-positive PSCs [<xref ref-type="bibr" rid="pone.0207321.ref028">28</xref>]. After culture in the presence of puromycin, we performed western blotting analysis and found that pERK levels were significantly elevated in <italic>Klf5</italic>-KO ESC lines compared with WT and <italic>Klf5</italic> heterozygous ESCs (<xref ref-type="fig" rid="pone.0207321.g001">Fig 1C and 1D</xref>).</p>
<fig id="pone.0207321.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0207321.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Klf5 suppresses pERK in mouse ESCs.</title>
<p>(A) Schematic representation of <italic>Klf5</italic> targeting vector to create <italic>Klf5</italic>-KO ESCs. (B) Expression of Klf5 protein in WT and <italic>Klf5</italic>-KO ESCs. Scale bar: 100 μm. (C) Western blot analysis of WT, <italic>Klf5</italic> heterozygous, and <italic>Klf5</italic>-KO ESCs. Western blot analysis was performed with antibodies against pERK, ERK, and β-actin. (D) Quantified signal intensity for pERK relative to ERK. Asterisk indicates statistical significance: *P &lt; 0.01; Mann-Whitney U test.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec004">
<title><italic>Klf5</italic>, but not <italic>Klf2</italic> or <italic>Klf4</italic>, rescues elevated pERK levels in <italic>Klf5</italic>-KO ESCs</title>
<p>Previous reports showed that <italic>Klf</italic> family members such as <italic>Klf2</italic>, <italic>Klf4</italic>, and <italic>Klf5</italic> have redundant functions to maintain the pluripotency of mouse ESCs [<xref ref-type="bibr" rid="pone.0207321.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0207321.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0207321.ref026">26</xref>]. To investigate whether <italic>Klf2</italic>, <italic>Klf4</italic>, and <italic>Klf5</italic> have similar functions on pERK regulation in mouse ESCs, epitope-tagged versions of Klf2, Klf4, or Klf5 were introduced into <italic>Klf5</italic>-KO ESCs and respective Klf-Tg ESC lines were established (<xref ref-type="fig" rid="pone.0207321.g002">Fig 2A</xref>). Expression levels of epitope-tagged Klf were similar to endogenous Klf5 expression in WT ESCs (<xref ref-type="fig" rid="pone.0207321.g002">Fig 2A</xref>). Elevated pERK levels in <italic>Klf5</italic>-KO ESCs were reversed to normal levels in WT ESCs by the introduction of Klf5, but not Klf2 or Klf4 (<xref ref-type="fig" rid="pone.0207321.g002">Fig 2A and 2B</xref>), indicating a unique Klf5 function on suppression of pERK. To more directly investigate whether Klf2 and Klf4 are involved in pERK regulation, we examined pERK levels in <italic>Klf2-</italic> or <italic>Klf4</italic>-KO ESCs by western blot analysis; no significant changes were observed (<xref ref-type="fig" rid="pone.0207321.g002">Fig 2C and 2D</xref>). Collectively, these results demonstrate a unique role for <italic>Klf5</italic> in pERK suppression in mouse ESCs.</p>
<fig id="pone.0207321.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0207321.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Rescue of elevated pERK levels in <italic>Klf5</italic>-KO ESCs by <italic>Klf5</italic>, but not <italic>Klf2</italic> or <italic>Klf4</italic>.</title>
<p>(A) Level of pERK in <italic>Klf5</italic>-KO ESCs overexpressing <italic>Klf2</italic>, <italic>Klf4</italic>, or <italic>Klf5</italic>. Western blot analysis of WT non-transgenic (non-Tg), empty vector (EV) control, <italic>Klf5</italic>-KO EV control, Klf2-overexpressing (Klf2_OE), Klf4_OE, and Klf5_OE ESCs were performed with antibodies against HA, Klf5, pERK, ERK, and β-actin. Exo; exogenous, endo; endogenous. (B) Quantified signal intensity for pERK relative to ERK. (C) Level of pERK in <italic>Klf2</italic>-or <italic>Klf4</italic>-KO ESCs. Western blot analysis of WT, <italic>Klf2</italic>-KO ESCs, and <italic>Klf4</italic>-KO ESCs. (D) Quantified signal intensity of pERK relative to ERK. Asterisk indicates statistical significance: *P &lt; 0.01; Mann-Whitney U test.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.g002" xlink:type="simple"/>
</fig>
<p>Given that pERK was elevated in <italic>Klf5</italic>-KO ESCs, we assessed whether expression of genes involved in the FGF-FGFR-ERK pathway were altered in <italic>Klf5</italic>-KO ESCs. RT-qPCR analysis indicated that <italic>Egr1</italic> is induced in <italic>Klf5</italic>-KO ESCs, consistent with the notion that <italic>Egr1</italic> is a direct target of ERK [<xref ref-type="bibr" rid="pone.0207321.ref029">29</xref>] and <italic>Spred1</italic> [<xref ref-type="bibr" rid="pone.0207321.ref030">30</xref>], a suppressor for ERK that was also significantly reduced in <italic>Klf5</italic>-KO ESCs (<xref ref-type="fig" rid="pone.0207321.g003">Fig 3A</xref>). To investigate whether <italic>Klf5</italic> binds to <italic>Spred1</italic> directly, we surveyed genomic binding sites of <italic>Klf5</italic> by examining ChIP-seq data and found that <italic>Spred1</italic> was occupied by Klf5 (<xref ref-type="fig" rid="pone.0207321.g003">Fig 3B</xref>). To confirm this finding, we used ESC lines overexpressing epitope-tagged Klf5, and found that Klf5 bound preferentially to <italic>Spred1</italic> loci (<xref ref-type="fig" rid="pone.0207321.g003">Fig 3C</xref>). These results indicated that Klf5 regulates <italic>Spred1</italic> to maintain proper pERK levels in mouse ESCs. Notably, <italic>Spred1</italic> was also occupied by Klf2 and Klf4 (<xref ref-type="fig" rid="pone.0207321.g003">Fig 3B and 3C</xref>), and the introduction of <italic>Klf2</italic> or <italic>Klf4</italic> significantly rescued <italic>Spred1</italic> expression (<xref ref-type="fig" rid="pone.0207321.g003">Fig 3D</xref>). These results indicated that Klf2 and Klf4 also have ability to activate transcription of <italic>Spred1</italic>. However, given that the elevated pERK level in <italic>Klf5</italic>-KO ESCs was reversed by Klf5, but not Klf2 or Klf4, we speculate that there may be other FGF-FGFR-ERK pathway-related molecules regulated by Klf5, but not Klf2 or Klf4.</p>
<fig id="pone.0207321.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0207321.g003</object-id>
<label>Fig 3</label>
<caption>
<title><italic>Klf5</italic> regulates <italic>Spred1</italic> in mouse ESCs.</title>
<p>(A) RT-qPCR analysis of genes involved in the FGF-FGFR-ERK pathway. (B) Binding peaks of Klf2, Klf4, and Klf5 to <italic>Spred1</italic> locus. Numbers below binding peaks indicate regions for ChIP primers. (C) Manual ChIP assay of Klf2, Klf4, and Klf5 binding to <italic>Spred1</italic> in mouse ESCs. (D) <italic>Spred1</italic> mRNA expression in <italic>Klf5</italic>-KO ESCs overexpressing <italic>Klf2</italic>, <italic>Klf4</italic>, or <italic>Klf5</italic>. Asterisks indicate statistical significance: *<italic>P</italic> &lt; 0.01, <italic>P</italic> &lt; 0.001** (Mann-Whitney U test).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.g003" xlink:type="simple"/>
</fig>
<p>Previous studies demonstrated that both Klf2 and Klf4 proteins are phosphorylated by ERK1/2 before proteolysis by the proteasome-degradation pathway [<xref ref-type="bibr" rid="pone.0207321.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0207321.ref031">31</xref>]. As pERK levels were elevated in <italic>Klf5</italic>-KO ESCs, we examined whether levels of Klf2 and Klf4 proteins were reduced (<xref ref-type="fig" rid="pone.0207321.g004">Fig 4A</xref>). Unexpectedly, levels of both Klf2 and Klf4 protein were significantly increased in <italic>Klf5</italic>-KO ESCs (<xref ref-type="fig" rid="pone.0207321.g004">Fig 4A and 4B</xref>). Thus, we examined mRNA levels and found that both <italic>Klf2</italic> and <italic>Klf4</italic> mRNA were significantly increased in <italic>Klf5</italic>-KO ESCs (<xref ref-type="fig" rid="pone.0207321.g004">Fig 4C</xref>). We speculate that compensatory upregulation of <italic>Klf2</italic> and <italic>Klf4</italic> mRNA may lead to an increase in both proteins, although degradation of <italic>Klf2</italic> and <italic>Klf4</italic> proteins may be promoted by elevated pERK.</p>
<fig id="pone.0207321.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0207321.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Levels of Klf2 and Klf4 in <italic>Klf5</italic>-KO ESCs.</title>
<p>(A) Western blot analysis of WT and <italic>Klf5</italic>-KO ESCs. Western blot analysis was performed with antibodies against Klf2, Klf4, and β-actin. (B) Quantified signal intensity of Klf2 or Klf4 relative to β-actin. (C) RT-qPCR analysis of <italic>Klf2</italic> and <italic>Klf4</italic> in WT and <italic>Klf5</italic>-KO ESCs.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec005">
<title>Klf5 facilitates reprogramming in combination with GSK3β inhibition</title>
<p>Mouse EpiSCs can be reprogrammed into Epi-iPSCs by induced expression of naïve transcription factors, such as Nanog and Esrrb, in the presence of 2i [<xref ref-type="bibr" rid="pone.0207321.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0207321.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0207321.ref032">32</xref>]. This system is widely used to evaluate the reprogramming ability of a putative reprogramming factor (<xref ref-type="fig" rid="pone.0207321.g005">Fig 5A</xref>). Previous studies reported that Klf2 and Klf4 have strong reprogramming activity from fibroblasts into iPSCs, whereas Klf5 has rather weak activity [<xref ref-type="bibr" rid="pone.0207321.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0207321.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0207321.ref024">24</xref>]. Similarly, <italic>Klf2</italic> and <italic>Klf4</italic> efficiently (0.1%–0.2%) facilitated the reprogramming of EpiSCs towards Epi-iPSCs, in contrast to <italic>Klf5</italic> (0%) [<xref ref-type="bibr" rid="pone.0207321.ref020">20</xref>]. We reassessed the effect of Klf2, Klf4, and Klf5 on reprogramming using EpiSCs overexpressing epitope-tagged versions of these Klf proteins, and confirmed that all three proteins were expressed at similar levels (<xref ref-type="fig" rid="pone.0207321.g005">Fig 5B</xref>). First, we examined the efficiency of reprogramming in a typical reprogramming medium [N2B27 medium containing a MEK inhibitor and GSK3ß inhibitor (2i)] by alkaline phosphatase (AP) assay and green fluorescent protein (GFP) fluorescence driven by ΔPE-Oct3/4 transgene activity, which is only present in naïve PSCs. It was observed that Klf2 and Klf4 had strong reprogramming activities (0.3%–0.5%) (<xref ref-type="fig" rid="pone.0207321.g005">Fig 5C and 5D</xref>). <italic>Klf5</italic> also had moderate activity (0.1%) (<xref ref-type="fig" rid="pone.0207321.g005">Fig 5C and 5D</xref>), consistent with our previous work [<xref ref-type="bibr" rid="pone.0207321.ref024">24</xref>]. Given that <italic>Klf5</italic> represses the FGF-ERK pathway in pre-implantation embryos [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>] and suppresses pERK in mouse ESCs (current study), we presumed that <italic>Klf5</italic> might facilitate the reprogramming process in place of a MEK inhibitor. Thus, we cultured EpiSCs in the absence of a MEK inhibitor, and found that Klf5 generated a substantial number of Oct3/4-positive colonies with greater efficiency than Klf2 or Klf4 (<xref ref-type="fig" rid="pone.0207321.g005">Fig 5E and 5F</xref>).</p>
<fig id="pone.0207321.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0207321.g005</object-id>
<label>Fig 5</label>
<caption>
<title><italic>Klf5</italic> facilitates reprogramming towards naïve pluripotency in combination with Chiron.</title>
<p>(A) Experimental design to evaluate the reprogramming activity of Klf proteins. EpiSCs (3 × 10<sup>4</sup>) were replated onto fibronectin-coated dishes and cultured in N2B27 medium containing 2i/LIF or Chiron/LIF. After 7 days in 2i/LIF or Chiron/LIF, iPSC colonies were picked for an AP assay. (B) Expression levels of epitope-tagged Klf2, Klf4, and Klf5 in EpiSCs. Open arrowheads indicate epitope-tagged Klf proteins. * indicates non-specific band. (C) Reprogramming ability of Klf2, Klf4, and Klf5 in the presence of 2i and LIF. Scale bar: 100 μm. (D) Comparison of reprogramming efficiency among <italic>Klf2</italic>, <italic>Klf4</italic>, and <italic>Klf5</italic> in the presence of 2i by AP assay and counting of GFP-positive colonies. (E) Reprogramming ability of Klf2, Klf4, and Klf5 in the presence of Chiron and LIF. Scale bar: 100 μm. (F) Comparison of reprogramming efficiency among <italic>Klf2</italic>, <italic>Klf4</italic>, and <italic>Klf5</italic> in the presence of Chiron by AP assay and counting of GFP-positive colonies.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.g005" xlink:type="simple"/>
</fig>
<p>Notably, the reprogramming efficiency elicited by Klf5 without MEK inhibition was higher than with MEK inhibition (<xref ref-type="fig" rid="pone.0207321.g005">Fig 5D and 5F</xref>). Recently, Yagi et al. and Choi et al. reported that prolonged culture in the presence of 1 μM MEK inhibitor causes loss of DNA methylation in mouse pluripotent stem cells, which erases of genomic imprinting and alters developmental potential into embryonic lineages [<xref ref-type="bibr" rid="pone.0207321.ref033">33</xref>,<xref ref-type="bibr" rid="pone.0207321.ref034">34</xref>]. Therefore, we speculated that treatment with 1 μM MEK inhibitor in combination with Klf5 may cause an additive effect for downstream genes, thereby reducing the reprogramming efficiency; although, the exact mechanism is currently unclear.</p>
<p>As Oct3/4-positive colonies exhibited very similar gene expression patterns to ESCs (<xref ref-type="fig" rid="pone.0207321.g006">Fig 6A</xref>), we performed blastocyst injections to examine the contribution of Oct3/4-positive cells to post-implantation embryos (<xref ref-type="fig" rid="pone.0207321.g006">Fig 6A and 6B</xref>). Injected embryos showed strong contributions to embryonic and postnatal chimeras (<xref ref-type="fig" rid="pone.0207321.g006">Fig 6B</xref>). These results suggest that Klf5 facilitates reprogramming in collaboration with GSK3β in the absence of a MEK inhibitor by regulating the FGF-ERK pathway.</p>
<fig id="pone.0207321.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0207321.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Chimera-forming ability of EpiSCs reprogrammed by Klf5 with Chiron/LIF.</title>
<p>Reprogrammed Epi-iPSCs show the hallmarks of naïve pluripotency. (A) RT-qPCR analysis of expression of markers for naive pluripotency and differentiation. After the Klf5 expression cassette was removed by transient Cre expression, RT-qPCR analysis was performed. Levels of expression relative to those in ESCs are shown. (B) Chimera generated from Epi-iPSCs induced by Klf5 in combination with Chiron. Upper panels show a control WT embryo and embryo injected with GFP-labeled Epi-iPSCs on the left and right, respectively. Lower panel shows a postnatal chimera at P10 injected with GFP-labeled Epi-iPSCs. Note that brown coat color indicates the contribution of 129 Epi-iPSCs. Plotted results are mean and SEM of three independent experiments. Scale bar: 100 μm.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.g006" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec006" sec-type="conclusions">
<title>Discussion</title>
<p>Although proper pERK levels are known to be required for maintenance of pluripotency, how pERK levels are properly controlled in mouse ESCs is not well understood. Thus far, extrinsic BMP4 attenuates ERK activity by inducing the ERK-specific phosphatase DUSP9 to promote self-renewal [<xref ref-type="bibr" rid="pone.0207321.ref035">35</xref>,<xref ref-type="bibr" rid="pone.0207321.ref036">36</xref>]. The MYC/MAX complex also suppresses ERK activity by regulating Dusp2 and Dusp7 to maintain the naïve state of PSCs, as a lack of MAX causes defective self-renewal and differentiation accompanied by ERK activation [<xref ref-type="bibr" rid="pone.0207321.ref037">37</xref>,<xref ref-type="bibr" rid="pone.0207321.ref038">38</xref>]. Our recent study showed that the transcription factor <italic>Klf5</italic> represses the ERK pathway via suppression of <italic>Fgf4</italic> in preimplantation mouse embryos [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>]. Although we previously showed that <italic>Fgf4</italic> is not altered in <italic>Klf5</italic>-KO ESCs [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>], current our study clearly indicates that Klf5 suppresses pERK in mouse ESCs via <italic>Spred1</italic>, a negative regulator for ERK signaling.</p>
<p>Previous reports have indicated that <italic>Klf2</italic>, <italic>Klf4</italic>, and <italic>Klf5</italic> have redundant functions in the self-renewal of mouse ESCs and in the induction of pluripotency [<xref ref-type="bibr" rid="pone.0207321.ref023">23</xref>]. However, it appears that <italic>Klf4</italic> and <italic>Klf5</italic> have differential roles on cellular proliferation [<xref ref-type="bibr" rid="pone.0207321.ref022">22</xref>]. Yeo et al. reported that Klf2 is directly phosphorylated by Erk2, and phospho-Klf2 undergoes proteasome-dependent degradation [<xref ref-type="bibr" rid="pone.0207321.ref025">25</xref>]. Therefore, inhibition of MEK can prevent Klf2 phosphorylation and stabilize Klf2 protein, thereby activating genes related to naïve pluripotency, which explains in part how MEK inhibition promotes the formation of naïve PSCs. Similarly, ERK phosphorylates Klf4 as part of the proteasome pathway [<xref ref-type="bibr" rid="pone.0207321.ref031">31</xref>]. In this regard, it is interesting to note that pERK was elevated in <italic>Klf5</italic>-KO ESCs and increased pERK could be reversed by overexpression of <italic>Klf5</italic>, but not <italic>Klf2</italic> or <italic>Klf4</italic>. Thus, these data clearly demonstrate a unique role for <italic>Klf5</italic> in the suppression of pERK in ESCs.</p>
<p>Taken together, our results clearly demonstrate that Klf5 is a critical genetic component that suppresses MEK activity in naïve PSCs.</p>
</sec>
<sec id="sec007" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec008">
<title>Pluripotent stem cells</title>
<p>Mouse <italic>Klf5</italic> hyg/floxed ESC lines were created by introducing a <italic>Klf5</italic> hygromycin-resistant gene knock-in vector [<xref ref-type="bibr" rid="pone.0207321.ref022">22</xref>] and floxed <italic>Klf5</italic> vector [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>] into OCRG9 ESCs (Oct3/4-CFP::Rex1-GFP-irespuroR, a generous gift from Dr. Niwa). Subsequently, pCAG-NLS-Cre (a generous gift from Dr. Andras Nagy, Samuel Lunenfeld Research Institute) was transiently introduced to delete the second and third exons of <italic>Klf5</italic>, thus generating <italic>Klf5</italic>-KO (hyg/Δ) ESC lines. ESCs were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS) in the presence of puromycin to enrich Oct3/4-positive PSCs. <italic>Klf2</italic>-floxed ESCs and <italic>Klf4</italic>-floxed ESCs were described previously [<xref ref-type="bibr" rid="pone.0207321.ref039">39</xref>].</p>
<p>OZ7 mouse EpiSCs, a generous gift from A. Smith [<xref ref-type="bibr" rid="pone.0207321.ref016">16</xref>], were maintained in N2B27 medium (Stem Cells Sciences) supplemented with 12 ng/μL basic fibroblast growth factor (bFGF) and 20 ng/μL activin A (R&amp;D Systems). To assay the reprogramming of EpiSCs, an effector plasmid expressing <italic>Klf2</italic>, <italic>Klf4</italic>, or <italic>Klf5</italic> was transfected into OZ7 cells using Lipofectamine 2000 (Invitrogen) and cells were cultured on fibronectin-coated dishes. Subsequently, EpiSCs (3 × 10<sup>4</sup>) were replated onto fibronectin-coated dishes and cultured in N2B27 medium containing 2i (1 μM PD0325901 and 3 μM CHIR99021)/LIF, or 3 μM Chiron/LIF. After 7 days in 2i/LIF or Chiron/LIF, iPSC colonies were picked or an AP assay was performed using an AP staining kit (Sigma-Aldrich).</p>
</sec>
<sec id="sec009">
<title>Immunohistochemistry and AP assay</title>
<p>PSCs were fixed in 4% paraformaldehyde for 10 min, permeabilized in 0.5% Triton X-100 for 10 min, and incubated in a blocking reagent [phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin and 0.01% Tween 20] for 1 hr. PSCs were incubated at 4°C overnight with primary antibodies (<xref ref-type="supplementary-material" rid="pone.0207321.s003">S1 Table</xref>). After three washes with PBS containing 0.2% Tween 20, secondary antibodies were incubated at room temperature for 1 hr. Nuclei were stained with Hoechst 33342 (10 μg/mL, Molecular Probes). AP assays to identify PSCs were performed with a leukocyte AP staining kit (Sigma-Aldrich).</p>
</sec>
<sec id="sec010">
<title>Blastocyst injection</title>
<p>The Klf5 expression unit was removed from Epi-iPSC lines reprogrammed from 129 EpiSCs, which were cultured in DMEM + 10% FBS and transfected with pPB-UbC-GFP plasmid and a transposase, as described in Jeon et al. [<xref ref-type="bibr" rid="pone.0207321.ref024">24</xref>]. GFP-positive Epi-iPSCs were harvested and injected into C57BL/6 mouse blastocysts (SLC Inc., Shizuoka, Japan), and chimeras were dissected out at E9.5 and E13.5. Some chimeras were analyzed for their coat color at postnatal day 10. The sacrifice was carried out by cervical dislocation. The experimental procedures were approved by the ethics committee for Animal Experimentation of Shiga University of Medical Sciences (Approval number: 2016-11-8) (Committee members are Akira Andoh, Jun Udagawa, Masatsugu Ema, Kazumasa Ogasawara, Shinichiro Nakamura, Kazuhiko Nozaki, Seiji Hitoshi, Kihachiro Horiike, Yoshihito Muroji, Shigehiro Morikawa). Masatsugu Ema was not involved in the judgement.</p>
</sec>
<sec id="sec011">
<title>Quantitative PCR analysis</title>
<p>For RT-PCR analysis, first-strand cDNA was synthesized from total RNA using a QuantiTect Reverse Transcription kit (Qiagen). Real-time PCR was performed with SYBR Premix Ex Taq II (TaKaRa) and analyzed on a Thermal Cycler Dice Real Time System (TP850; TaKaRa). Amounts of target RNA were estimated using an appropriate standard curve and normalized by dividing values by the estimated amount of β-actin. Sequences of primers used for quantitative PCR are listed in <xref ref-type="supplementary-material" rid="pone.0207321.s004">S2 Table</xref>.</p>
</sec>
<sec id="sec012">
<title>Western blot analysis</title>
<p>ESCs were lysed and western blotting was performed as described previously [<xref ref-type="bibr" rid="pone.0207321.ref022">22</xref>]. Membranes were immunoblotted with rat anti-mouse Klf5 antibody (KM1784; Kyowa Kirin), rabbit anti-pERK antibody (Cell Signaling Technology), rabbit anti-ERK antibody (Cell Signaling Technology), rabbit anti-Klf2 antibody (Millipore), rabbit anti-Klf4 antibody (Abcam), or anti-β-actin antibody (MBL), followed by an appropriate secondary antibody [horseradish peroxidase-conjugated rabbit anti-mouse IgG (Invitrogen) or horseradish peroxidase-conjugated goat anti-rabbit IgG (Zymax)]. Immunoreactive proteins were detected using enhanced chemiluminescence (Chemilumi One; Nakalai) and an ImageQuant LAS 4000 imager (GE Healthcare). Signal intensity of western blotting was quantified using ImageJ. Signals were normalized to the intensity of ERK or β-actin.</p>
</sec>
<sec id="sec013">
<title>Chromatin immunoprecipitation (ChIP)-sequencing data analysis</title>
<p>Data analysis was performed as described previously [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>]. ChIP-seq data were downloaded from the EMBLE-EBI site [Klf2: ERR440998, Klf4: SRR952210, Klf5: SRR952211, Aksoy et al., 2014]. ChIP-seq reads were located to the mouse reference genome (mm9) using Burrows-Wheeler alignment software. Uniquely mapped reads were used for peak calling by CCAT3 version 3.0. Peak regions were filtered for false discovery rate values &lt; 0.05. RefSeq genes that had a Klf5 binding site within 20 kb were identified by determining the overlap between ChIP-seq peak regions and RefSeq genes extended by 20 kb in both directions. To visualize ChIP-seq tag counts in the UCSC Genome Browser, mapped reads were extended and converted into the bedGrapgh format using the genomecov function of BEDTools.</p>
</sec>
<sec id="sec014">
<title>Chromatin immunoprecipitation assays</title>
<p>ChIP assay was performed as described previously [<xref ref-type="bibr" rid="pone.0207321.ref027">27</xref>]. Sequences of primers used for ChIP-qPCR are listed in <xref ref-type="supplementary-material" rid="pone.0207321.s005">S3 Table</xref>.</p>
</sec>
<sec id="sec015">
<title>Statistical analysis</title>
<p>Statistical analyses were performed using the Mann-Whitney U test. Data are expressed as mean and standard error (SEM). Differences were considered significant at <italic>P</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="sec016">
<title>Supporting information</title>
<supplementary-material id="pone.0207321.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Raw data for western blot analysis.</title>
<p>Uncropped western blot images shown in Figures are presented.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0207321.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Raw data for western blot analysis.</title>
<p>Uncropped western blot images shown in Figures are presented.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0207321.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.s003" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>List of antibodies used in this study.</title>
<p>Antibodies used in this study are presented.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0207321.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.s004" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>List of qRT-PCR primers.</title>
<p>Primer sequences for qRT-PCR analysis are presented.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0207321.s005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0207321.s005" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>List of ChIP-qPCR primers.</title>
<p>Primer sequences for ChIP-qPCR analysis are presented.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Dr. T. Tsukiyama for helpful discussion and reagents. This work was supported in part by a grant from PRESTO, Japan Science and Technology Agency (M. E.). We thank Edanz Group (<ext-link ext-link-type="uri" xlink:href="http://www.edanzediting.com/ac" xlink:type="simple">www.edanzediting.com/ac</ext-link>) for editing a draft of this manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0207321.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Evans</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Kaufman</surname> <given-names>MH</given-names></name>. <article-title>Establishment in culture of pluripotential cells from mouse embryos</article-title>. <source>Nature</source>. <year>1981</year>;<volume>292</volume>: <fpage>154</fpage>–<lpage>156</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/292154a0" xlink:type="simple">10.1038/292154a0</ext-link></comment> <object-id pub-id-type="pmid">7242681</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname> <given-names>GR</given-names></name>. <article-title>Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells</article-title>. <source>Proc Natl Acad Sci</source>. <year>1981</year>;<volume>78</volume>: <fpage>7634</fpage>–<lpage>7638</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.78.12.7634" xlink:type="simple">10.1073/pnas.78.12.7634</ext-link></comment> <object-id pub-id-type="pmid">6950406</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takahashi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yamanaka</surname> <given-names>S</given-names></name>. <article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>. <source>Cell</source>. <year>2006</year>;<volume>126</volume>: <fpage>663</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2006.07.024" xlink:type="simple">10.1016/j.cell.2006.07.024</ext-link></comment> <object-id pub-id-type="pmid">16904174</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Heath</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Donaldson</surname> <given-names>DD</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>GG</given-names></name>, <name name-style="western"><surname>Moreau</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stahl</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides</article-title>. <source>Nature</source>. <year>1988</year>;<volume>336</volume>: <fpage>688</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/336688a0" xlink:type="simple">10.1038/336688a0</ext-link></comment> <object-id pub-id-type="pmid">3143917</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niwa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ogawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Shimosato</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Adachi</surname> <given-names>K</given-names></name>. <article-title>A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells</article-title>. <source>Nature</source>. <year>2009</year>;<volume>460</volume>: <fpage>118</fpage>–<lpage>122</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature08113" xlink:type="simple">10.1038/nature08113</ext-link></comment> <object-id pub-id-type="pmid">19571885</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chambers</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Colby</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Robertson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells</article-title>. <source>Cell</source>. <year>2003</year>;<volume>113</volume>: <fpage>643</fpage>–<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0092-8674(03)00392-1" xlink:type="simple">10.1016/S0092-8674(03)00392-1</ext-link></comment> <object-id pub-id-type="pmid">12787505</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mitsui</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tokuzawa</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Itoh</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Segawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Murakami</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells</article-title>. <source>Cell</source>. <year>2003</year>;<volume>113</volume>: <fpage>631</fpage>–<lpage>42</lpage>. <object-id pub-id-type="pmid">12787504</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Masui</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nakatake</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Toyooka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shimosato</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Yagi</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells</article-title>. <source>Nat Cell Biol</source>. <year>2007</year>;<volume>9</volume>: <fpage>625</fpage>–<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb1589" xlink:type="simple">10.1038/ncb1589</ext-link></comment> <object-id pub-id-type="pmid">17515932</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zevnik</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Anastassiadis</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Niwa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Klewe-Nebenius</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Chambers</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Formation of pluripotent stem cells in the mammalian embryo dependes on the POU transcription factor Oct4</article-title>. <source>Cell</source>. <year>1998</year>;<volume>95</volume>: <fpage>379</fpage>–<lpage>391</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0092-8674(00)81769-9" xlink:type="simple">10.1016/S0092-8674(00)81769-9</ext-link></comment> <object-id pub-id-type="pmid">9814708</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ying</surname> <given-names>Q-L</given-names></name>, <name name-style="western"><surname>Wray</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Batlle-Morera</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Doble</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Woodgett</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>The ground state of embryonic stem cell self-renewal</article-title>. <source>Nature</source>. <year>2008</year>;<volume>453</volume>: <fpage>519</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature06968" xlink:type="simple">10.1038/nature06968</ext-link></comment> <object-id pub-id-type="pmid">18497825</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kunath</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Saba-El-Leil</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Almousailleakh</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wray</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Meloche</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>A</given-names></name>. <article-title>FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment</article-title>. <source>Development</source>. <year>2007</year>;<volume>134</volume>: <fpage>2895</fpage>–<lpage>902</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.02880" xlink:type="simple">10.1242/dev.02880</ext-link></comment> <object-id pub-id-type="pmid">17660198</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hamilton</surname> <given-names>WB</given-names></name>, <name name-style="western"><surname>Kaji</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kunath</surname> <given-names>T</given-names></name>. <article-title>ERK2 suppresses self-renewal capacity of embryonic stem cells, but is not required for multi-lineage commitment</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>: <fpage>e60907</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0060907" xlink:type="simple">10.1371/journal.pone.0060907</ext-link></comment> <object-id pub-id-type="pmid">23613754</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brons</surname> <given-names>IGM</given-names></name>, <name name-style="western"><surname>Smithers</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Trotter</surname> <given-names>MWB</given-names></name>, <name name-style="western"><surname>Rugg-Gunn</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Chuva de Sousa Lopes</surname> <given-names>SM</given-names></name>, <etal>et al</etal>. <article-title>Derivation of pluripotent epiblast stem cells from mammalian embryos</article-title>. <source>Nature</source>. <year>2007</year>;<volume>448</volume>: <fpage>191</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature05950" xlink:type="simple">10.1038/nature05950</ext-link></comment> <object-id pub-id-type="pmid">17597762</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tesar</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Chenoweth</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Brook</surname> <given-names>FA</given-names></name>, <name name-style="western"><surname>Davies</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>EP</given-names></name>, <name name-style="western"><surname>Mack</surname> <given-names>DL</given-names></name>, <etal>et al</etal>. <article-title>New cell lines from mouse epiblast share defining features with human embryonic stem cells</article-title>. <source>Nature</source>. <year>2007</year>;<volume>448</volume>: <fpage>196</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature05972" xlink:type="simple">10.1038/nature05972</ext-link></comment> <object-id pub-id-type="pmid">17597760</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>A</given-names></name>. <article-title>Naive and primed pluripotent states</article-title>. <source>Cell Stem Cell. Cell Press</source>; <year>2009</year>;<volume>4</volume>: <fpage>487</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2009.05.015" xlink:type="simple">10.1016/j.stem.2009.05.015</ext-link></comment> <object-id pub-id-type="pmid">19497275</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hall</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Eyres</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Mansfield</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Klf4 reverts developmentally programmed restriction of ground state pluripotency</article-title>. <source>Development</source>. <year>2009</year>;<volume>136</volume>: <fpage>1063</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.030957" xlink:type="simple">10.1242/dev.030957</ext-link></comment> <object-id pub-id-type="pmid">19224983</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ten Berge</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kurek</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Blauwkamp</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Koole</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Maas</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Eroglu</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells</article-title>. <source>Nat Cell Biol</source>. <year>2011</year>;<volume>13</volume>: <fpage>1070</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb2314" xlink:type="simple">10.1038/ncb2314</ext-link></comment> <object-id pub-id-type="pmid">21841791</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takashima</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Loos</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ficz</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Krueger</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Resetting transcription factor control circuitry toward ground-state pluripotency in human</article-title>. <source>Cell</source>. <year>2014</year>;<volume>158</volume>: <fpage>1254</fpage>–<lpage>1269</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2014.08.029" xlink:type="simple">10.1016/j.cell.2014.08.029</ext-link></comment> <object-id pub-id-type="pmid">25215486</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Silva</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Theunissen</surname> <given-names>TW</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>van Oosten</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Barrandon</surname> <given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Nanog is the gateway to the pluripotent ground state</article-title>. <source>Cell</source>. <year>2009</year>;<volume>138</volume>: <fpage>722</fpage>–<lpage>37</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2009.07.039" xlink:type="simple">10.1016/j.cell.2009.07.039</ext-link></comment> <object-id pub-id-type="pmid">19703398</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref020"><label>20</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Hall</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wray</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Eyres</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Grotewold</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <chapter-title>Oct4 and LIF/Stat3 Additively Induce Krüppel Factors to Sustain Embryonic Stem Cell Self-Renewal</chapter-title>. <source>Cell Stem Cell. Elsevier Ltd</source>; <year>2009</year>;<volume>5</volume>: <fpage>597</fpage>–<lpage>609</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2009.11.003" xlink:type="simple">10.1016/j.stem.2009.11.003</ext-link></comment> <object-id pub-id-type="pmid">19951688</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>Y-S</given-names></name>, <name name-style="western"><surname>Loh</surname> <given-names>Y-H</given-names></name>, <name name-style="western"><surname>Cai</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tong</surname> <given-names>G-Q</given-names></name>, <name name-style="western"><surname>Lim</surname> <given-names>C-A</given-names></name>, <etal>et al</etal>. <article-title>A core Klf circuitry regulates self-renewal of embryonic stem cells</article-title>. <source>Nat Cell Biol</source>. <year>2008</year>;<volume>10</volume>: <fpage>353</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb1698" xlink:type="simple">10.1038/ncb1698</ext-link></comment> <object-id pub-id-type="pmid">18264089</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ema</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mori</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Niwa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hasegawa</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yamanaka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hitoshi</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs</article-title>. <source>Cell Stem Cell</source>. <year>2008</year>;<volume>3</volume>: <fpage>555</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2008.09.003" xlink:type="simple">10.1016/j.stem.2008.09.003</ext-link></comment> <object-id pub-id-type="pmid">18983969</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakagawa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Koyanagi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tanabe</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ichisaka</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Aoi</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts</article-title>. <source>Nat Biotechnol</source>. <year>2008</year>;<volume>26</volume>: <fpage>101</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt1374" xlink:type="simple">10.1038/nbt1374</ext-link></comment> <object-id pub-id-type="pmid">18059259</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jeon</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Waku</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Azami</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Khoa</surname> <given-names>LTP</given-names></name>, <name name-style="western"><surname>Yanagisawa</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Comprehensive Identification of Krüppel-Like Factor Family Members Contributing to the Self-Renewal of Mouse Embryonic Stem Cells and Cellular Reprogramming</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>: <fpage>e0150715</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0150715" xlink:type="simple">10.1371/journal.pone.0150715</ext-link></comment> <object-id pub-id-type="pmid">26943822</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yeo</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>ZY</given-names></name>, <name name-style="western"><surname>Yim</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Ng</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Göke</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Klf2 is an essential factor that sustains ground state pluripotency</article-title>. <source>Cell Stem Cell</source>. <year>2014</year>;<volume>14</volume>: <fpage>864</fpage>–<lpage>872</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2014.04.015" xlink:type="simple">10.1016/j.stem.2014.04.015</ext-link></comment> <object-id pub-id-type="pmid">24905170</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamane</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ohtsuka</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Matsuura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nakamura</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Niwa</surname> <given-names>H</given-names></name>. <article-title>Overlapping function of klf family targets multiple transcription factors to maintain naïve pluripotency of ES cells</article-title>. <source>Development</source>. <year>2018</year>;<volume>145</volume>: dev162404. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.162404" xlink:type="simple">10.1242/dev.162404</ext-link></comment> <object-id pub-id-type="pmid">29739838</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Azami</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Waku</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Jeon</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Muratani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kawashima</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Klf5 maintains the balance of primitive endoderm versus epiblast specification during mouse embryonic development by suppression of Fgf4</article-title>. <source>Development</source>. <year>2017</year>;<volume>144</volume>: <fpage>3706</fpage>–<lpage>3718</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.150755" xlink:type="simple">10.1242/dev.150755</ext-link></comment> <object-id pub-id-type="pmid">28870993</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Toyooka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shimosato</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Murakami</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Niwa</surname> <given-names>H</given-names></name>. <article-title>Identification and characterization of subpopulations in undifferentiated ES cell culture</article-title>. <source>Development</source>. <year>2008</year>;<volume>135</volume>: <fpage>909</fpage>–<lpage>18</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.017400" xlink:type="simple">10.1242/dev.017400</ext-link></comment> <object-id pub-id-type="pmid">18263842</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Shen</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>M-L</given-names></name>, <name name-style="western"><surname>Pan</surname> <given-names>F-Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Jia</surname> <given-names>W-P</given-names></name>, <etal>et al</etal>. <article-title>Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice</article-title>. <source>EMBO J</source>. <year>2011</year>;<volume>30</volume>: <fpage>3754</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/emboj.2011.277" xlink:type="simple">10.1038/emboj.2011.277</ext-link></comment> <object-id pub-id-type="pmid">21829168</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wakioka</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sasaki</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kato</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Shouda</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Miyoshi</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Spred is a sprouty-related suppressor of Ras signalling</article-title>. <source>Nature</source>. <year>2001</year>;<volume>412</volume>: <fpage>647</fpage>–<lpage>651</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/35088082" xlink:type="simple">10.1038/35088082</ext-link></comment> <object-id pub-id-type="pmid">11493923</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>MO</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>S-H</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>Y-Y</given-names></name>, <name name-style="western"><surname>Nadas</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jeong</surname> <given-names>C-H</given-names></name>, <name name-style="western"><surname>Yao</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4</article-title>. <source>Nat Struct Mol Biol</source>. <year>2012</year>;<volume>19</volume>: <fpage>283</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nsmb.2217" xlink:type="simple">10.1038/nsmb.2217</ext-link></comment> <object-id pub-id-type="pmid">22307056</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Festuccia</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Osorno</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Halbritter</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Karwacki-Neisius</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Navarro</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Colby</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells</article-title>. <source>Cell Stem Cell</source>. <year>2012</year>;<volume>11</volume>: <fpage>477</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2012.08.002" xlink:type="simple">10.1016/j.stem.2012.08.002</ext-link></comment> <object-id pub-id-type="pmid">23040477</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yagi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kishigami</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Semi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mizutani</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wakayama</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation</article-title>. <source>Nature</source>. <year>2017</year>;<volume>548</volume>: <fpage>224</fpage>–<lpage>227</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature23286" xlink:type="simple">10.1038/nature23286</ext-link></comment> <object-id pub-id-type="pmid">28746308</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Huebner</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Clement</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Walsh</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Savol</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells</article-title>. <source>Nature</source>. <year>2017</year>;<volume>548</volume>: <fpage>219</fpage>–<lpage>223</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature23274" xlink:type="simple">10.1038/nature23274</ext-link></comment> <object-id pub-id-type="pmid">28746311</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qi</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>T-G</given-names></name>, <name name-style="western"><surname>Hao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Simmons</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2004</year>;<volume>101</volume>: <fpage>6027</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0401367101" xlink:type="simple">10.1073/pnas.0401367101</ext-link></comment> <object-id pub-id-type="pmid">15075392</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Fei</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>BMP4 Signaling Acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells</article-title>. <source>Cell Stem Cell</source>. <year>2012</year>;<volume>10</volume>: <fpage>171</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2011.12.016" xlink:type="simple">10.1016/j.stem.2011.12.016</ext-link></comment> <object-id pub-id-type="pmid">22305567</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hishida</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Nozaki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Nakachi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Mizuno</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Okazaki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ema</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Indefinite self-renewal of ESCs through Myc/Max transcriptional complex-independent mechanisms</article-title>. <source>Cell Stem Cell</source>. <year>2011</year>;<volume>9</volume>: <fpage>37</fpage>–<lpage>49</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2011.04.020" xlink:type="simple">10.1016/j.stem.2011.04.020</ext-link></comment> <object-id pub-id-type="pmid">21726832</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chappell</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Singh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dalton</surname> <given-names>S</given-names></name>. <article-title>MYC/MAX control ERK signaling and pluripotency by regulation of dual-specificity phosphatases 2 and 7</article-title>. <source>Genes Dev</source>. <year>2013</year>;<volume>27</volume>: <fpage>725</fpage>–<lpage>733</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.211300.112" xlink:type="simple">10.1101/gad.211300.112</ext-link></comment> <object-id pub-id-type="pmid">23592794</object-id></mixed-citation></ref>
<ref id="pone.0207321.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamane</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ohtsuka</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Matsuura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nakamura</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Niwa</surname> <given-names>H</given-names></name>. <article-title>Overlapping functions of Krüppel-like factor family members: targeting multiple transcription factors to maintain the naïve pluripotency of mouse embryonic stem cells</article-title>. <source>Development</source>. <year>2018</year>;<volume>145</volume>: dev162404. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.162404" xlink:type="simple">10.1242/dev.162404</ext-link></comment> <object-id pub-id-type="pmid">29739838</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>